Whayland Elizabeth A

Avg. Two Year Performance

No purchase track record
50% Avg. Sale Return
23% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(9%)(13%)(43%)(22%)0%
Purchase Success Rate0 of 10 of 10 of 10 of 10 of 1
Average Sale Return14%10%9%31%50%
Sale Success Rate1 of 21 of 21 of 22 of 22 of 2

CuraGen Corp.

Drugs » Biotechnology

SVP of Finance, Secretary:

Holdings: 300.21K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--